duplicate enrollment in research

Verified Clinical Trials (VCT) is proud to announce our participation at the upcoming American Diabetes Association (ADA) annual meeting. As clinical research in diabetes, obesity, and GLP-1 therapies continues to expand at a record pace, VCT remains committed to delivering innovative solutions that safeguard data integrity, improve participant safety, and optimize trial outcomes by preventing …

Read more

The race to develop and commercialize GLP-1-based therapies for obesity and diabetes has created unprecedented momentum in clinical research. Dozens of sponsors and CROs are simultaneously conducting trials—often in overlapping geographic regions—with many vying for access to the same pool of patients. While this represents exciting progress in metabolic disease treatment, it also presents a …

Read more

https://healthtechcurated.com/regulatory-and-compliance/how-does-vct-protect-clinical-trials-from-duplicate-subjects/ In the complex realm of clinical trials, preventing the enrollment of duplicate and professional research subjects is critical for maintaining data integrity and ensuring participant safety. As trials expand with overlapping indications and global participation, the risk of unethical subject enrollment increases. These duplicate reseaerch subjects, who join multiple studies without observing necessary washout …

Read more

Detecting and preventing protocol violations before they ever happen. In today’s complex clinical trial landscape, one issue continues to fly under the radar—duplicate research subjects and professional research subjects. These individuals enroll in multiple trials simultaneously or too close together, often crossing therapeutic areas, sponsors, and trial phases. Left unchecked, these subjects introduce significant risk …

Read more

The Verified Clinical Trials (VCT) team is excited to attend the 2025 ASCP Annual Meeting, currently taking place in Tucson, Arizona. As the premier event hosted by the American Society of Clinical Psychopharmacology, ASCP brings together global leaders advancing psychiatry and CNS (central nervous system) drug development—and VCT is proud to support that mission. Verified …

Read more

In the world of clinical research, ensuring participant safety and preserving data integrity are not just goals—they are regulatory and scientific necessities. Yet, a significant blind spot persists in the industry: duplicate subjects in clinical trials and professional research subjects continue to slip through the cracks, threatening the quality of clinical trials globally. Verified Clinical …

Read more

In the high-stakes world of clinical research, every data point matters. However, a growing and often underestimated threat continues to jeopardize clinical trial outcomes: professional patients in clinical trials. Professional patients—also known as duplicate subjects in clinical trials —are individuals who enroll in multiple clinical trials simultaneously or in rapid succession, often hiding their participation …

Read more

In the world of drug development and medical innovation, clinical trials are the backbone of progress. However, the integrity of these trials is increasingly compromised by a rising and often overlooked issue: professional patients, also known as duplicate subjects in Clinical Trials. Who Are Professional Patients? Professional patients are individuals who enroll in multiple clinical …

Read more

GARDEN CITY, N.Y.–(BUSINESS WIRE)–Verified Clinical Trials (VCT), the world’s largest global research subject database designed to prevent dual enrollment in clinical trials with duplicate research subjects and protocol violations in clinical trials, proudly announces it has achieved ISO/IEC 27001 certification, the international gold standard for information security management systems (ISMS). This significant milestone reflects VCT’s ongoing dedication to …

Read more

Running a successful clinical trial requires precision, compliance, and above all—integrity of your data. One of the greatest threats to this integrity? Professional research subjects and duplicate subjects in clinical trials. Many sponsors and CROs underestimate the frequency and impact of dual enrollment in clinical trials. Yet, it’s not a matter of if it will …

Read more